1. Home
  2. Browse
  3. Respiratory & Allergy
  4. COPD
  5. Treatment

Treatment

61 - 75 of 118 Results
Sort Results:
Commentary: Tudorza Pressair (Aclidinium) December 2012
Commentary: Safety of Long-Acting Beta-Agonists in Asthma November 2012
Commentary: New Formulation: Combivent Respimat September 2012
Article: Combivent Respimat (ipratropium/albuterol) September 2012
Guideline: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease UPDATED 2010 January 2012
Commentary: New Drug: Arcapta (Indacaterol) January 2012
Article: Arcapta (ar-CAP-ta), a new inhaled long-acting beta-agonist for COPD January 2012
Article: You'll finally see Primatene Mist (epinephrine) disappear and the new Combivent Respimat appear November 2011
Commentary: Market Withdrawal of Primatene Mist (Epinephrine) Inhalers November 2011
Other: FDA Podcast: Withdrawal of Primatene Mist (April 2011) November 2011
Article: chronic azithromycin to PREVENT recurrent COPD exacerbations October 2011
Commentary: Azithromycin to Prevent COPD Exacerbations October 2011
Commentary: Spiriva (Tiotropium) vs Long-Acting Beta-2 Agonists for COPD August 2011
Article: Daliresp (DA-li-resp), a new oral tablet for severe COPD in patients with chronic bronchitis July 2011
Commentary: New Drug: Daliresp (Roflumilast) July 2011